Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy

Nesrine Benkafadar(Inserm), Jing Wang(Inserm)
EMBO Molecular Medicine
October 28, 2016
Cited by 106


Related Papers